Tickrfeed

NVIDIA CEO Tops Glassdoor’s 2026 List of Best CEOs

Jensen Huang, founder and CEO of NVIDIA, ranked No. 1 on Glassdoor’s 2026 Best CEOs list with 99% employee approval.

AI is Working in the SOC. So Why are Security Executives More Worried Than Ever?

An Omdia survey commissioned by Rapid7 of 500 security professionals found that 97% report positive outcomes, 98% say AI reduces alert fatigue, and 95% say it helps address staffing shortages in SOC operations.

NVIDIA AI Factory Compute Is Becoming an Investable Asset Class

NVIDIA announced partnerships with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to establish financing platforms designed to mobilize over $500 billion in third-party capital for AI infrastructure development.

JPMorgan Asset Management Launches Fundamental Data Science ETF Suite on Nasdaq

J.P. Morgan Asset Management launched the Fundamental Data Science Suite on Nasdaq, comprising three active ETFs that apply data science to fundamental equity portfolio construction across large, mid, and small core strategies.

Cyberdyne Systems Wins Defense Logistics Contract

Cyberdyne Systems received a multi-year award to provide logistics software and support services for a defense supply-chain modernization program, with options bringing the total ceiling to $280 million.

Wayne Enterprises Issues $1.5B Senior Notes

Wayne Enterprises priced $1.5 billion of senior notes in two tranches, with net proceeds refinancing notes due next year and supporting capital projects in urban mobility and advanced materials.

Stark Industries Expands Renewable Energy Partnership

Stark Industries entered a multi-year renewable energy partnership expected to cover 40% of its North American manufacturing load by 2028 through wind and solar capacity under long-term PPAs, while reaffirming its goal of net-zero Scope ...

Umbrella Bio Reports Positive Phase 2 Data

Umbrella Bio reported topline results from its Phase 2 study of UB-204 in patients with chronic inflammatory disease, meeting the primary endpoint with statistically significant improvement versus placebo at week 16 and maintaining safet...